April SAS-B figures: pastilles hit nearly one-third of approvals by Adam Sheldon May 7, 2026May 7, 2026 Approvals through the Special Access Scheme fell below 20,000 in April, as pastilles continued to cement […]
Survey of 239 patients suggests CBG may benefit pain, sleep and anxiety by Adam Sheldon March 9, 2026March 10, 2026
Family experience of MC drives Medibis to fund autism anxiety trial by Adam Sheldon August 5, 2025August 19, 2025
SAS-B data highlights concerning trend towards prescribing THC for anxiety by Steve Jones October 11, 2023October 11, 2023
